ENDRA Life Sciences Inc. Common Stock NDRA
$4.70
-6.01%
at last close
Analyst Consensus
- Consensus Rating
- Buy (1 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $25.00
- Implied Upside
- +431.5%
- Price Target Range
- $25.00 – $25.00
- Analysts (12 mo)
- 1
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-06-01 | Ascendiant CapitalEdward Woo |
Maintains | Buy | $27 → $25 |
| 2025-12-08 | Ascendiant CapitalEdward Woo |
Maintains | Buy | $38 → $30 |
| 2025-09-22 | Ascendiant CapitalEdward Woo |
Maintains | Buy | $46 → $38 |
| 2025-05-30 | Ascendiant CapitalEdward Woo |
Maintains | Buy | $50 → $46 |
| 2025-04-21 | Ascendiant CapitalEdward Woo |
Maintains | Buy | $75 → $50 |
| 2024-06-07 | Ascendiant CapitalEdward Woo |
Maintains | Buy | $17500 → $14000 |
| 2023-03-31 | HC Wainwright & Co.Vernon Bernardino |
Reiterates | Buy | $175000 → $15750 |
| 2022-04-07 | HC Wainwright & Co.Vernon Bernardino |
Maintains | Buy | $210000 → $175000 |
| 2019-07-15 | HC Wainwright & Co.Vernon Bernardino |
Initiates coverage on | Buy | $210000 |
| 2019-05-20 | Lake Street |
Initiates coverage on | Buy | — |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $4.70
- Market Cap
- $7.51 million
- 52-Week Range
- $2.96 – $9.85
- Average Volume
- 15K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.